6[4]Hunter JC,Fontanna DJ,Hedley LR,et al.Assessment of the role of alpha 2-adrenoceptor subtypes in the antinociceptive,sedative and hypothermic action of dexmedetomidine in transgenic mice[J].Br J Pharmacol,1997;122:1339-1344.
7[5]Nelson LE,Lu J,Guo TZ,et al.The α2-Adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects[J].Anesthesiology,2003;98:428-436.
8[6]Coull JT,Jones M,Egan T,et al.Attentionla effects of noradranaline vary with arousal level:selective activation of thalamie pulvinar in humans[J].Neuro Image,2004;22:315-322.
9[7]Eisenach JC.[Alpha]2 agonists and analgesia[J].Exp Opin Invest Drugs,1994;3:1005-1010.
10[8]Ma D,Rajakumamswamy N,Maze M.Alpha2-Adrenoceptor agonists:shedding light on neuroprotection?[J].Br Med Bull,2005;71:77-92.
8KENIYA V M, LADI S, NAPHADE R. Dexmedetomidine attenu- ates sympathoadrenal response to tracheal intubation and reduces perioperative anaesthetic requirement [ J ]. India J Anaesth, 2011, 55(4) : 352 -357.
9TSAI C J, CHU K S, CHEN T I, et al. A comparison of the effec- tiveness of dexmedetomidine versus propofol target - controlled in- fusion for sedation during fibreoptic nasotracheal intubation [ J 1. Anaesthesia, 2010, 65(3): 254-259.
10ISMAIL S, AZAM S I, KHAN F A. Effect of age on haemodynamie response to tracheal intubation. A comparison of young, middle - aged and elderly patients[ J]. Anaesth Intensive Care, 2002, 30 (5) : 608 -614.
